AR026705A1 - Forma triturada - Google Patents
Forma trituradaInfo
- Publication number
- AR026705A1 AR026705A1 ARP000106385A ARP000106385A AR026705A1 AR 026705 A1 AR026705 A1 AR 026705A1 AR P000106385 A ARP000106385 A AR P000106385A AR P000106385 A ARP000106385 A AR P000106385A AR 026705 A1 AR026705 A1 AR 026705A1
- Authority
- AR
- Argentina
- Prior art keywords
- refers
- compound
- pharmaceutically acceptable
- reduced particle
- particle size
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 4
- 239000002245 particle Substances 0.000 abstract 4
- 150000003839 salts Chemical class 0.000 abstract 4
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000012453 solvate Substances 0.000 abstract 2
- -1 4-tert-butoxycarbonylaminophenyl Chemical group 0.000 abstract 1
- 208000031773 Insulin resistance syndrome Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
- C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente se refiere a un tamano de partícula reducido del compuesto ácido 3-{4-[2-(4-terc-butoxicarbonilaminofenil)etoxi]fenil}-(S)-2-etoxi propanoico,segun formula (1) o su sal farmacéuticamente aceptable o un solvato de cualquiera de ellos. La p resente también se refiere a los métodos para tratar una o máscondiciones asociadas con el Síndrome de Resistencia a la Insulina usando la forma de tamano de partícula reducido del compuesto, o su sal farmacéuticamenteaceptable para la fabricacion de un medicamento para usar para una o más de dichas condiciones. La presente también se refiere a las composicionesfarmacéuticas que contienen la forma de tamano de partícula reducido del compuesto, o su sal farmacéuticamente aceptable, o su solvato, como ingrediente activo, así como también se refiere a los procesos para la fabricacion de la forma de tamano de partícula reducido del compuesto o su sal farmacéuticamente aceptable.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9904412A SE9904412D0 (sv) | 1999-12-03 | 1999-12-03 | Comminuted form |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR026705A1 true AR026705A1 (es) | 2003-02-26 |
Family
ID=20417977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000106385A AR026705A1 (es) | 1999-12-03 | 2000-12-01 | Forma triturada |
Country Status (5)
| Country | Link |
|---|---|
| AR (1) | AR026705A1 (es) |
| AU (1) | AU2034701A (es) |
| CO (1) | CO5271723A1 (es) |
| SE (1) | SE9904412D0 (es) |
| WO (1) | WO2001040166A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6369067B1 (en) | 1997-10-27 | 2002-04-09 | Dr. Reddy's Research Foundation | Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
| RU2235094C2 (ru) | 1997-10-27 | 2004-08-27 | Др. Редди`З Лабораториз Лимитед | Бета-арил-альфа-оксизамещенные алкилкарбоновые кислоты, способы их получения, промежуточные соединения, способы их получения, фармацевтическая композиция, способы лечения или предупреждения заболеваний на основе новых соединений |
| AU752059B2 (en) | 1997-10-27 | 2002-09-05 | Dr. Reddy's Laboratories Limited | Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| US6130214A (en) | 1997-10-27 | 2000-10-10 | Dr. Reddy's Research Foundation | Benzothiazin and benzoxazin derivatives; their preparation and uses |
| US6440961B1 (en) | 1997-10-27 | 2002-08-27 | Dr. Reddy's Research Foundation | Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
| KR20010085876A (ko) | 1998-10-29 | 2001-09-07 | 닥터 레디스 리서치 파운데이숀 | 신규의 항당뇨제의 개선된 제조방법 |
| US6531596B1 (en) | 1998-10-29 | 2003-03-11 | Dr. Reddy's Laboratories Ltd. | Process for the preparation of new antidiabetic agents |
| US6897199B2 (en) | 2001-02-05 | 2005-05-24 | Dr. Reddy's Laboratories Ltd. | Pharmaceutically acceptable salts of phenoxazine and phenothiazine compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9801990D0 (sv) * | 1998-06-04 | 1998-06-04 | Astra Ab | New 3-aryl propionic acid derivatives and analogs |
| MA26634A1 (fr) * | 1998-06-04 | 2004-12-20 | Astra Ab | Nouveaux derives de l'acide 3-aryl propionique et analogues |
-
1999
- 1999-12-03 SE SE9904412A patent/SE9904412D0/xx unknown
-
2000
- 2000-11-29 WO PCT/SE2000/002380 patent/WO2001040166A1/en active Application Filing
- 2000-11-29 CO CO00091394A patent/CO5271723A1/es not_active Application Discontinuation
- 2000-11-29 AU AU20347/01A patent/AU2034701A/en not_active Abandoned
- 2000-12-01 AR ARP000106385A patent/AR026705A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001040166A1 (en) | 2001-06-07 |
| AU2034701A (en) | 2001-06-12 |
| CO5271723A1 (es) | 2003-04-30 |
| SE9904412D0 (sv) | 1999-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR029456A1 (es) | Forma triturada | |
| AR072755A2 (es) | Comprimido de carga de droga alta del compuesto 4-(4-metilpiperazin-1-ilmetil)-n-[4-metil-3-(4-piridin-3-il)pirimidin-2-ilamino)fenil]-benzamida | |
| EA201000643A1 (ru) | Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе | |
| NO20076613L (no) | Farmasoytiske formuleringer og anvendelse derav | |
| CO6160236A2 (es) | Inhibidor de quinasa | |
| GT200000216A (es) | Oxazolidinonas sustituidas y su uso. | |
| AR067495A1 (es) | Composiciones farmaceuticas y procedimientode tratamientos de trastornos de ojo seco | |
| NO20060126L (no) | Substituerte aryltioureaderivater nyttige som inhibitorer av viral replikasjon | |
| AR056575A1 (es) | Compuesto de (alfa)-aminocarboxiamida que es 5-(4-[[(2-fluorofenil) metil] oxi] fenil)prolinamida, composicion farmaceutica que lo comprende, su uso para la fabricacion de un medicamento y proceso para prepararlo | |
| AR048431A1 (es) | Formulaciones galenicas de compuestos organicos | |
| GT200100183A (es) | Derivados de quinolina y quinazolina. | |
| AR054234A1 (es) | Composicion farmaceutica para el tratamiento del cancer | |
| AR063707A1 (es) | Determinadas amidas sustituidas, el uso de las mismas para el tratamiento de enfermedades mediadas por la inhibicion de la actividad de btk y composiciones farmacéuticas que las comprenden. | |
| PT1119543E (pt) | N-aralquilaminotetralinas como ligandos para o receptor y5 do neuropeptido y | |
| SE0301882D0 (sv) | New use I | |
| HN2004000232A (es) | " derivados de pirrolo(3,4-c) pirazol activos como inhibidores de quinasa, proceso para su preparacion y composiciones farmaceuticas que los comprenden." | |
| GT200600163A (es) | Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de la depresion | |
| AR033688A1 (es) | Composicion parenteral reconstituible | |
| UY27886A1 (es) | Composicion farmaceutica que tiene una distribucion y potencia uniforme de farmaco. | |
| AR062393A1 (es) | Uso de derivado del 2.5-dihidrixibenceno para el tratamiento de artritis y dolor | |
| UY29085A1 (es) | Derivados de pirimidina 4-sulfonamido sustituidos, compuestos intermedios para su preparación, procedimientos de preparación, composiciones medicinales conteniéndolos y aplicaci0nes | |
| UY27018A1 (es) | Derivados de la pirimidina | |
| AR007021A1 (es) | Derivados de 3-descladinosa-2,3-anhidroeritromicina, procedimientos para su preparacion, compuestos para su exclusivo uso en dichos procedimientosy procedimiento para su preparacion, una composicion farmaceutica para tratar infecciones bacterianas y el uso de estos compuestos para preparar medicamentos | |
| AR026705A1 (es) | Forma triturada | |
| AR048336A1 (es) | Hidrocloruro de (4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il)-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |